Lista de obras - Diego Arango - Dominio Público Uruguay

7q deletion mapping and expression profiling in uterine fibroids.

artículo científico publicado en 2005

A gene expression profile that defines colon cell maturation in vitro.

artículo científico publicado en 2002

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

artículo científico publicado en 2006

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

artículo científico publicado en 2018

An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression

artículo científico publicado en 2009

Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function

artículo científico publicado en 2013

Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

artículo científico publicado en 2010

Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.

artículo científico publicado en 2003

Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.

artículo científico

BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation

artículo científico publicado en 2001

BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts

scientific article published on 01 January 1999

Brush border myosin Ia has tumor suppressor activity in the intestine.

artículo científico publicado en 2012

Brush border myosin Ia inactivation in gastric but not endometrial tumors

artículo científico publicado en 2012

Cancer stem cells and personalized cancer nanomedicine.

artículo científico publicado en 2016

Candidate driver genes in microsatellite-unstable colorectal cancer

artículo científico publicado en 2011

Clinical response to fluorouracil and p53.

artículo científico publicado en 2001

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

artículo científico publicado en 2014

Customizing chemotherapy for colon cancer: the potential of gene expression profiling.

artículo científico publicado en 2004

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.

artículo científico publicado en 2018

Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.

artículo científico publicado en 2006

Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine

scientific article published on 01 February 2001

Distinct expression profile in fumarate-hydratase-deficient uterine fibroids

artículo científico publicado en 2005

Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

artículo científico publicado en 2004

Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols

artículo científico publicado en 2000

Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.

artículo científico publicado en 2016

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells

article

EPH receptors in cancer.

artículo científico publicado en 2008

EPHB4 and survival of colorectal cancer patients.

artículo científico publicado en 2006

Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.

artículo científico publicado en 2008

Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

artículo científico publicado en 2023

Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells

artículo científico publicado en 2015

Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

artículo científico publicado en 2003

Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

artículo científico publicado en 2005

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

artículo científico publicado en 2005

Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families

article

HDAC4 promotes growth of colon cancer cells via repression of p21.

artículo científico publicado en 2008

High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.

artículo científico publicado en 2006

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment

artículo científico publicado en 2015

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

artículo científico publicado en 2006

Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.

artículo científico publicado en 2012

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells

artículo científico publicado en 2020

Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.

artículo científico publicado en 2017

Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

artículo científico publicado en 2017

Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.

artículo científico publicado en 2005

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

artículo científico publicado en 2017

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

artículo científico publicado en 2009

Microarray analysis in the clinical management of cancer ⬇️

artículo científico publicado el 1 de abril de 2003

Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.

artículo científico publicado en 2006

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

artículo científico publicado en 2004

Mutations in the circadian gene CLOCK in colorectal cancer

artículo científico publicado en 2010

Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers

artículo científico publicado en 2005

Myo5b knockout mice as a model of microvillus inclusion disease.

artículo científico publicado en 2015

Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT

artículo científico publicado en 2006

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer

scientific article published on 19 June 2019

Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.

artículo científico publicado en 2002

Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression

artículo científico publicado en 2003

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

artículo científico

PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.

artículo científico publicado en 2015

RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.

artículo científico publicado en 2014

SMAD4 as a Prognostic Marker in Colorectal Cancer

artículo científico publicado en 2005

SMAD4 levels and response to 5-fluorouracil in colorectal cancer

artículo científico publicado en 2005

Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis

artículo científico publicado en 2006

Short chain fatty acids and colon cancer

artículo científico publicado en 2002

Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.

artículo científico publicado en 2018

TR3/Nur77 in colon cancer cell apoptosis.

artículo científico publicado en 2003

The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner

artículo científico publicado en 2014

The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.

artículo científico publicado en 2015

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

artículo científico publicado en 2009

Transforming pathways unleashed by a HDAC2 mutation in human cancer.

artículo científico publicado en 2008

Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer

artículo científico publicado en 2004

Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

artículo científico publicado en 2006

Unregulated smooth-muscle myosin in human intestinal neoplasia

artículo científico publicado en 2008

Villin expression is frequently lost in poorly differentiated colon cancer.

artículo científico publicado en 2012

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

artículo científico publicado en 2003

c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.

artículo científico publicado en 2001

Lista de obras de Diego Arango

7q deletion mapping and expression profiling in uterine fibroids.

A gene expression profile that defines colon cell maturation in vitro.

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression

Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function

Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

Application of gene expression profiling to colon cell maturation, transformation and chemoprevention.

Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.

BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation

BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts

Brush border myosin Ia has tumor suppressor activity in the intestine.

Brush border myosin Ia inactivation in gastric but not endometrial tumors

Cancer stem cells and personalized cancer nanomedicine.

Candidate driver genes in microsatellite-unstable colorectal cancer

Clinical response to fluorouracil and p53.

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

Customizing chemotherapy for colon cancer: the potential of gene expression profiling.

DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.

Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine.

Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine

Distinct expression profile in fumarate-hydratase-deficient uterine fibroids

Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status

Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols

Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells

EPH receptors in cancer.

EPHB4 and survival of colorectal cancer patients.

Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.

Extracellular vesicles secreted by triple‐negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells

Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin.

Gene expression signatures for colorectal cancer microsatellite status and HNPCC.

Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer

Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families

HDAC4 promotes growth of colon cancer cells via repression of p21.

High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.

Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment

Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer

Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.

Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells

Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.

Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

Microarray analysis in the clinical management of cancer ⬇️

Modeling tumor predisposing FH mutations in yeast: effects on fumarase activity, growth phenotype and gene expression profile.

Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.

Mutations in the circadian gene CLOCK in colorectal cancer

Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers

Myo5b knockout mice as a model of microvillus inclusion disease.

Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT

Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer

Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.

Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression

PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab

PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.

RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.

SMAD4 as a Prognostic Marker in Colorectal Cancer

SMAD4 levels and response to 5-fluorouracil in colorectal cancer

Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis

Short chain fatty acids and colon cancer

Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.

TR3/Nur77 in colon cancer cell apoptosis.

The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner

The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Transforming pathways unleashed by a HDAC2 mutation in human cancer.

Tumor necrosis factor-alpha related gene response to Epothilone B in ovarian cancer

Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells

Unregulated smooth-muscle myosin in human intestinal neoplasia

Villin expression is frequently lost in poorly differentiated colon cancer.

c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.